Zeiss
ZEISS is an internationally leading technology company that develops, produces and distributes highly innovative solutions for industrial metrology, microscopy solutions, as well as medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery.
ZEISS intraoperative radiotherapy (IORT) solution, INTRABEAM 600, delivers a single tumouricidal dose to a well-defined target directly after tumour resection, while sparing adjacent organs at risk using low-energy x-ray photons at a high dose rate. Combining surgery and irradiation into one step, this approach ensures local precision during tumour bed sterilisation, for truly personalised treatments. Benefits of IORT for the patient are vast, with a reduced overall treatment time meaning that most patients can return to their families and daily routine much faster, when compared with external beam radiotherapy.
ZEISS’ advancement of novel treatment applicators allows to conform radiation dosage to various target volumes, enabling the usage of IORT in not only breast applications, but also brain and spine. With more than 300 devices globally, the ZEISS INTRABEAM 600 is supported by a robust and conclusive body of evidence which confirms the clinical value of personalised and patient-centric IORT treatment options. www.zeiss.com/intrabeam
